Gastrointestinal Cancer

In a good percentage of patients who have oligometastatic disease confined to a single organ—usually the liver—complete metastasectomy can result in cure. However, once the decision to pursue surgery is made, there remain a number of issues that must be addressed in order to ensure the best possible outcome.

Gastrointestinal Cancer

We have yet to establish a standard practice for maintenance therapy in metastatic colorectal cancer. Of course, ideally we could find a biomarker of benefit for patients who should be managed this way, but thus far we have had no such luck.

The addition of cetuximab to chemotherapy containing oxaliplatin and fluorouracil resulted in a significantly shorter progression-free survival in patients with operable KRAS exon 2 wild-type colorectal cancer liver metastases, according to results of a recent study.

The greater distance a patient had to travel to reach a diagnosing facility the more likely that patient was to present with a higher stage disease of colon cancer, according to the results of a recent study.

A high body mass index prior to a colorectal cancer diagnosis is linked to a higher risk of death, even when the patient’s tumor type is generally associated with a better prognosis.

A new study reports that a multitarget stool DNA test is sensitive and accurate and is an improvement over previous DNA stool-based detection tests.

The rates of colon cancer in US adults aged 50 and older have decreased by 3% per year over the last 10 years, with the largest decrease seen in those over the age of 65.

Current evidence suggests that only four DPYD and TYMS variants should make up the panel of genetic biomarkers for testing for toxicity to capecitabine monotherapy, according to the results of a recent study.


Subscribe to
Please Wait 20 seconds or click here to close